268 related articles for article (PubMed ID: 23899616)
1. Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.
Fonseca-Berzal C; Merchán Arenas DR; Romero Bohórquez AR; Escario JA; Kouznetsov VV; Gómez-Barrio A
Bioorg Med Chem Lett; 2013 Sep; 23(17):4851-6. PubMed ID: 23899616
[TBL] [Abstract][Full Text] [Related]
2. In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents.
Fonseca-Berzal C; Rojas Ruiz FA; Escario JA; Kouznetsov VV; Gómez-Barrio A
Bioorg Med Chem Lett; 2014 Feb; 24(4):1209-13. PubMed ID: 24461296
[TBL] [Abstract][Full Text] [Related]
3. Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi.
Rolón M; Seco EM; Vega C; Nogal JJ; Escario JA; Gómez-Barrio A; Malpartida F
Int J Antimicrob Agents; 2006 Aug; 28(2):104-9. PubMed ID: 16844353
[TBL] [Abstract][Full Text] [Related]
4.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
5. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
[TBL] [Abstract][Full Text] [Related]
7. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
[TBL] [Abstract][Full Text] [Related]
8. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
[TBL] [Abstract][Full Text] [Related]
9. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant
Fonseca-Berzal C; da Silva CF; Batista DDGJ; de Oliveira GM; Cumella J; Batista MM; Peres RB; Silva da Gama Nefertiti A; Escario JA; Gómez-Barrio A; Arán VJ; Soeiro MNC
Parasitology; 2020 Sep; 147(11):1216-1228. PubMed ID: 32530391
[TBL] [Abstract][Full Text] [Related]
10. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
[TBL] [Abstract][Full Text] [Related]
11. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
[TBL] [Abstract][Full Text] [Related]
12. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.
Vinuesa T; Herráez R; Oliver L; Elizondo E; Acarregui A; Esquisabel A; Pedraz JL; Ventosa N; Veciana J; Viñas M
Am J Trop Med Hyg; 2017 Nov; 97(5):1469-1476. PubMed ID: 29016287
[TBL] [Abstract][Full Text] [Related]
13. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.
Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes.
Nirdé P; Larroque C; Barnabé C
C R Acad Sci III; 1995 Dec; 318(12):1239-44. PubMed ID: 8745639
[TBL] [Abstract][Full Text] [Related]
16. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
18. Activity of natural and synthetic polygodial derivatives against
Turner DN; Just J; Dasari R; Smith JA; Bissember AC; Kornienko A; Rogelj S
Nat Prod Res; 2021 Mar; 35(5):792-795. PubMed ID: 31032640
[TBL] [Abstract][Full Text] [Related]
19. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
